Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy: PIK3CA activating mutations in invasive lobular breast carcinoma. (2023). Radiology and Oncology, 57(2), 220-228. https://www.radioloncol.com/index.php/ro/article/view/4055